In a 24-week double-blind study, the most commonly observed symptoms (skin irritation rating scale) with Prometax 9.5 mg/ 24 h transdermal patches were very slight (21.8 %), mild (12.5 %) or moderate (6.5 %) erythema or very slight (11.9 %), mild (7.3 %) or moderate (5.0 %) pruritus.
V 24- tedenski dvojno slepi študiji so bili najbolj pogosto opaženi simptomi (po lestvici ocene draženja kože) s transdermalnimi obliži Prometax 9, 5 mg/ 24 h zelo blaga (21, 8 %), blaga (12, 5 %) ali zmerna (6, 5 %) rdečina ali zelo blago (11, 9 %), blago (7, 3 %) ali zmerno (5, 0 %) srbenje.